BAD | Jotup

Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies

Retrieved on:

목요일, 2월 8, 2024

Health care, Dialysis, BAD, Hemofiltration, Kidney, Mortality, FDA, Food, Food and Drug Administration, Fresenius Medical Care, Convection, Diffusion, Engineering, Patient, Water, FME, Blood, Medical device

Fresenius Medical Care (FME) receives U.S. Food and Drug Administration (FDA) 510(k) clearance of the company's 5008X Hemodialysis System.

Key Points:

Fresenius Medical Care (FME) receives U.S. Food and Drug Administration (FDA) 510(k) clearance of the company's 5008X Hemodialysis System.
This will enable Fresenius Medical Care to offer the industry-leading, high-volume hemodiafiltration (Hv-HDF) dialysis therapy – already widely used in Europe – for people living with kidney diseases in the U.S.
The 510(k) clearance allows the start of clinical evaluations and user-studies in the U.S., with a planned broad commercial launch of the 5008X Hemodialysis System in 2025.
The 5008X Hemodialysis System and companion FX CorAL dialyzer demonstrate the company's global innovation leadership in medical device and membrane engineering technologies.

Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board

Retrieved on:

월요일, 2월 5, 2024

Supervisory board, Works council, BAD, Supervision, Fresenius Medical Care, Patient, Workforce, FME, IGBCE, Beata, Aktiengesellschaft, Sankt Wendel, Kidney, Woman

BAD HOMBURG, Germany, Feb. 5, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has nominated six employee representatives as members of the company's Supervisory Board.

Key Points:

BAD HOMBURG, Germany, Feb. 5, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has nominated six employee representatives as members of the company's Supervisory Board.
Fresenius Medical Care successfully completed its change of legal form into a German stock corporation (Aktiengesellschaft, AG) on November 30, 2023, which also included the formation of a new Supervisory Board, which initially consisted of the six shareholder representatives.
The appointed members of the Supervisory Board are:
Stefanie Balling, Chairwoman of the General Works Council of Fresenius Medical Care in Germany, and Chairwoman of the local works council at the Schweinfurt site (Care Enablement)
Beate Haßdenteufel, Deputy Chairwoman of the Works Council at the St. Wendel site (Care Enablement)
Michael Sen, Chairman of the Supervisory Board of Fresenius Medical Care AG, says: "The proposed employee representatives provide a broad range of experience and knowledge to the Supervisory Board.
Following the appointment, Fresenius Medical Care is preparing the election of the employee representatives to the Supervisory Board, following legal requirements.

Bad Idea AI and K9 Finance Announce Strategic Partnership to Enhance Community Engagement and Technological Synergy

Retrieved on:

화요일, 1월 30, 2024

Ethereum, Partnership, BAD, Knowledge, AI, Machine learning, Ecosystem, Intelligence, Creativity, Artificial intelligence, K9

Playing a critical role in this development, Bad Idea AI's chatbot has been incorporated into K9 Finance's community.

Key Points:

Playing a critical role in this development, Bad Idea AI's chatbot has been incorporated into K9 Finance's community.
Specifically, a custom mode was created for the AI, and one of the first tasks was to integrate the AI so that it could assume a persona tailored for the K9 Finance community.
And Buzz, K9 Finance DAO founder and development lead, expressed his thoughts, "Bad Idea AI is one of those projects that is always willing to help support others.
If you would like more information about this partnership and the future implications, please visit Bad Idea AI and K9 Finance .

Maxon Red Giant Update Delivers Fast, Beautiful Bokeh and Realistic Lens Flares

Retrieved on:

수요일, 1월 17, 2024

Cloud, Giant, Human physical appearance, UE, BAD, Life, Magic bullet, Tracker, Particular, Form, Effect, Unreal Engine, Red giant, VFX, Video game

BAD HOMBURG, Germany, Jan. 17, 2024 /PRNewswire-PRWeb/ -- Maxon, developers of professional software solutions for editors, filmmakers, motion designers, visual effects artists, and creators of all types, today announced wide-ranging updates to Red Giant 2024.

Key Points:

Universe offers editors and compositors an essential toolkit of effects and transitions and now it's even easier to add dream bokeh to any shot.
New Bokeh plugin allows artists to quickly create beautiful bokeh and mimic camera focus without the need for a complex camera lens setup.
Bokeh Transition, a variant of the Bokeh plugin, helps artists seamlessly transition between two clips using a dazzling de-focus effect.
Highlighting Trapcode's new cloud service support, Maxon has added two new sprite categories for emojis and pixel art.

STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara

Retrieved on:

수요일, 1월 10, 2024

Biosimilar competition in the €2.5 billion (US$2.7 billion) EU ustekinumab market could significantly expand patient access to this life-changing biologic therapy within gastroenterology, dermatology, and rheumatology.

Key Points:

Biosimilar competition in the €2.5 billion (US$2.7 billion) EU ustekinumab market could significantly expand patient access to this life-changing biologic therapy within gastroenterology, dermatology, and rheumatology.
STADA’s Global Specialty Head, Bryan Kim, commented: “This first marketing authorization for biosimilar ustekinumab in Europe offers the potential to expand substantially patient access through competition.
Under a strategic partnership begun in 2019, Alvotech is primarily responsible for developing and manufacturing the AVT04 ustekinumab biosimilar.
These include a high-concentration, citrate-free adalimumab biosimilar developed and marketed through the partnership between Alvotech and STADA.

December Release Features Improved Adobe Substance 3D, Unreal, glTF Integrations

Retrieved on:

월요일, 12월 11, 2023

Data, Symmetry, Plant, TRS, Collection, BAD, Unreal Engine, Neuron, Forsythia, Cinema 4D, Organic, RT, GlTF, Nvidia, 3D printing, Cryptocurrency, Camera, Capsule, Unreal, Redshift

BAD HOMBURG, Germany, Dec. 11, 2023 /PRNewswire-PRWeb/ -- Maxon, developers of professional software solutions for editors, filmmakers, motion designers, visual effects artists and creators of all types, today announced comprehensive updates to several products included in the Maxon One subscription offering. Cinema 4D now features enhanced integration with Adobe Substance 3D materials, faster and easier file exchange with Unreal and the addition of glTF animation import. The December Release also brings improvements to many features in Cinema 4D, performance and image quality boosts for Redshift RT and valuable additions to Capsules including numerous assets, as well as a new Spline Modifier by Rocket Lasso.

Key Points:

Cinema 4D now features enhanced integration with Adobe Substance 3D materials, faster and easier file exchange with Unreal and the addition of glTF animation import.
Please note: Maxon is currently offering a limited time offer to get Maxon One and Adobe Substance 3D at a special discount price.
Offers improved workflows and features to help artists stay on top of their projects and assets, art-direct simulations with more precision and make the most out of their Maxon One subscription with Adobe Substance 3D.
Artists can simply drag and drop Adobe Substance 3D materials directly into Cinema 4D to create new Redshift materials.

Maxon One: Critical Enhancements for ZBrush in November Release

Retrieved on:

목요일, 11월 16, 2023

ZBrush, Plant, Collection, Northern Lights, BAD, Unreal Engine, Capsule, Stroke, Cinema 4D, Tree, Transpose, Gizmo, 3D printing, Toy, Cosmetics, Redshift

BAD HOMBURG, Germany, Nov. 16, 2023 /PRNewswire-PRWeb/ -- Maxon, developers of professional software solutions for editors, filmmakers, motion designers, visual effects artists and creators of all types, today announced comprehensive updates to several products included in the Maxon One subscription offering, including improvements for ZBrush, Cineware and a batch of new Capsules. The industry standard for digital painting and sculpting, ZBrush, is better than ever - with improvements to the Anchors Brush that was introduced in July, giving users new ways to manipulate meshes. Additional enhancements offer more control when using the Knife Brush and make it easier to repeat changes on a mesh. Cineware offers an improved import of Cinema 4D files into Unreal Engine and extends support for Redshift materials.

Key Points:

The latest updates to Maxon One include improvements for ZBrush, Cineware and the largest Capsules drop to date.
Additional enhancements offer more control when using the Knife Brush and make it easier to repeat changes on a mesh.
ZBrush 2024 comes with a number of improvements that make the industry standard for digital sculpting even better.
ZBrush 2024 comes with a number of improvements that make the industry standard for digital sculpting even better.

Maxon Redshift and Cinebench Optimized for Mac Lineup with M3 Family of Chips

Retrieved on:

화요일, 10월 31, 2023

BAD, Architecture, Cinema 4D, MacOS, GPU, Maxon, Creativity, Video game, Creative industries, M3, Redshift, Microsoft Windows, Apple

BAD HOMBURG, Germany, Oct. 31, 2023 /PRNewswire-PRWeb/ -- Maxon is thrilled to announce updates to Redshift and Cinebench 2024 that take advantage of the latest developments in Apple's M3 family of chips. Artists will experience outstanding performance when generating photorealistic imagery using Maxon's industry-leading Redshift render engine, thanks to the increased GPU power of the M3 family of chips, which includes support for hardware-accelerated ray tracing. Maxon's Cinebench 2024 benchmarking tool, built on Redshift and Maxon's Cinema 4D, is fully optimized and available as a free download, offering creators to evaluate the performance of Apple's M3-series chips.

Key Points:

BAD HOMBURG, Germany, Oct. 31, 2023 /PRNewswire-PRWeb/ -- Maxon is thrilled to announce updates to Redshift and Cinebench 2024 that take advantage of the latest developments in Apple's M3 family of chips.
Artists will experience outstanding performance when generating photorealistic imagery using Maxon's industry-leading Redshift render engine, thanks to the increased GPU power of the M3 family of chips, which includes support for hardware-accelerated ray tracing.
Maxon's Cinebench 2024 benchmarking tool, built on Redshift and Maxon's Cinema 4D, is fully optimized and available as a free download, offering creators to evaluate the performance of Apple's M3-series chips.
Optimizations will be available as part of regular Redshift updates for Maxon One and Redshift subscribers in the coming months.

Maxon Explores Past, Present and Future of Motion Graphics at NAB New York 2023

Retrieved on:

수요일, 10월 18, 2023

BAD HOMBURG, Germany, Oct. 18, 2023 /PRNewswire-PRWeb/ -- Maxon, developers of professional software solutions for editors, filmmakers, motion designers, visual effects artists and creators of all types, is excited to announce their presence at NAB New York 2023, accompanied by another incredible lineup of talented presenters at booth 927. Taking place from October 24 - 26, 2023, this event offers attendees the chance to discover the latest releases and updates within Maxon's state-of-the-art software while bringing together some of the most talented creative minds in the industry.

Key Points:

Exploring the past, present and future of art, presenters will showcase a variety of projects inspired by impactful memories and built from archived galleries, including designing cyborgs and predicting the future of motion graphics.
Exploring the past, present and future of art, presenters will showcase a variety of projects inspired by impactful memories and built from archived galleries, including designing cyborgs and predicting the future of motion graphics.
Visitors are also invited to use Maxon's exclusive code "NY3627" to register for NAB New York for free.
Speakers at Maxon's NAB New York 2023 showcase include:
Anthony Bari Jr is a technical consultant for Adobe, Blackmagic Design, Maxon, and more with Emmy award-winning post-production experience.

LBank Exchange Will List Bad Idea AI (BAD) on October 7, 2023

Retrieved on:

금요일, 10월 6, 2023

AI, Intuition, Bad Idea, Knowledge, Dame Alice Owen's School, Human, BAD, Intelligence, Medical device, Customer service, Blockchain

Road Town, British Virgin Islands--(Newsfile Corp. - October 6, 2023) - LBank Exchange, a global digital asset trading platform, will list Bad Idea AI (BAD) on October 8, 2023.

Key Points:

Road Town, British Virgin Islands--(Newsfile Corp. - October 6, 2023) - LBank Exchange, a global digital asset trading platform, will list Bad Idea AI (BAD) on October 8, 2023.
For all users of LBank Exchange, the BAD/USDT trading pair will be officially available for trading at 8:00 UTC on October 7, 2023.
Bad Idea AI (BAD) is an experimental decentralized project that combines Blockchain, AI, and DAOs to explore shared governance dynamics between AI agents and human DAOs, testing the interplay between human intuition and AI computational capabilities in decision-making, with the goal of shaping the future through this innovative fusion of technology and human input.
Bad Idea AI represents an unprecedented alliance between humans and AI, aiming to strike a delicate balance between human intuition and AI's computational prowess.